Advertisements



Novartis Reports Data on Cosentyx for Psoriatic Arthritis

Novartis (NVS) announces new data .....»»

Category: personnelSource: nytJun 12th, 2019

Novartis Reports Positive Long-Term Data From Cosentyx Trials

Novartis (NVS) announces encouraging five-year data from late-stage studies on Cosentyx for psoriatic arthritis and ankylosing spondylitis indications. Novartis NVS reported encouraging five-year data from ongoing extensions of the .....»»

Category: smallbizSource: nytOct 18th, 2018

Novartis (NVS) Reports Positive Phase III Data on Asthma Drug

Novartis' (NVS) investigational, once-daily, fixed dose combination asthma candidate, containing indacaterol acetate and momet.....»»

Category: dealsSource: nytMay 31st, 2019

Novartis Reports Data on Asthma Drug, Update from Annual Meet

Zacks.....»»

Category: topSource: redinewsMay 24th, 2019

Novartis (NVS) Reports Encouraging Data on MS Candidate

Novartis (NVS) announces encouraging .....»»

Category: worldSource: nytApr 20th, 2018

Your Daily Pharma Scoop: XBiotech Reports Positive Data, AstraZeneca"s New Approval, Novartis" Positive MS Trial

Your Daily Pharma Scoop: XBiotech Reports Positive Data, AstraZeneca"s New Approval, Novartis" Positive MS Trial.....»»

Category: topSource: seekingalphaSep 17th, 2018

Novartis: 5-year Cosentyx studies data backs leadership in spondyloarthritis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2018

Amgen reports Phase 3 results of Enbrel monotherapy in psoriatic arthritis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2018

Mallinckrodt Presents Encouraging Data on Acthar Gel for RA

Mallinckrodt (MNK) reports encouraging results from a phase IV study on Acthar for RA at the EUL.....»»

Category: dealsSource: nytJun 14th, 2019

Bristol-Myers reports updated efficacy data from Phase 2 Empliciti combo trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2019

Novartis: follow-up data from ENESTfreedom, ENESTop trials show sustained TFR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2019

Concert Pharma"s CTP-692 Positive for Schizophrenia in Phase I

Concert Pharma (CNCE) reports favorable data from the two early-stage studies on its pipeline candidate, CTP-692, currently under evaluation as an adjunctive treatment for schizophre.....»»

Category: dealsSource: nytJun 13th, 2019

Amazon boosts hiring in China, data shows, Yahoo Finance reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2019

Mortgage applications surge as rates continue to drop

CNBC's Diana Olick reports on the latest mortgage application data......»»

Category: realestateSource: cnbcJun 12th, 2019

UK April pay data beats forecasts, employment growth slows

British wages in the three months to April grew faster than expected and hiring slowed less sharply, as the jobless rate held at its lowest rate since 1975, official figures showed on Tuesday. Francis Maguire reports......»»

Category: videoSource: reutersJun 11th, 2019

CymaBay reports topline 12-week data from ongoing Phase 2b study of seladelpar

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2019

The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 10) read more.....»»

Category: blogSource: benzingaJun 11th, 2019

The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-.....»»

Category: earningsSource: benzingaJun 11th, 2019

Dr. Reddy"s Reports Positive Top-Line Data on Psoriasis Drug

Dr. Reddy's (RDY) reports positive top-line results from the phase IIb study on PPC-06 (formerly referred to as XP23829) in patients with moderate.....»»

Category: worldSource: nytJun 10th, 2019

Dr. Reddy"s Reports Positive Top-Line Data on Psoriasis Drug

Dr Reddy s Laboratories.....»»

Category: futuresSource: nasdaqJun 10th, 2019

Aptinyx reports top-line data from Phase 2 study of NYX-2925

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 10th, 2019